Securian Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.98M Sell
13,442
-156
-1% -$69.5K 0.17% 107
2025
Q1
$6.59M Sell
13,598
-211
-2% -$102K 0.2% 98
2024
Q4
$5.56M Sell
13,809
-435
-3% -$175K 0.16% 107
2024
Q3
$6.62M Sell
14,244
-551
-4% -$256K 0.19% 91
2024
Q2
$6.93M Sell
14,795
-384
-3% -$180K 0.2% 92
2024
Q1
$6.34M Sell
15,179
-1,145
-7% -$479K 0.19% 100
2023
Q4
$6.64M Sell
16,324
-2,177
-12% -$886K 0.19% 94
2023
Q3
$6.43M Sell
18,501
-3,131
-14% -$1.09M 0.19% 100
2023
Q2
$7.61M Sell
21,632
-270
-1% -$95K 0.2% 101
2023
Q1
$6.9M Buy
21,902
+168
+0.8% +$52.9K 0.18% 109
2022
Q4
$6.28M Buy
21,734
+216
+1% +$62.4K 0.18% 117
2022
Q3
$6.23M Buy
21,518
+228
+1% +$66K 0.19% 100
2022
Q2
$6M Hold
21,290
0.14% 152
2022
Q1
$5.56M Sell
21,290
-233
-1% -$60.8K 0.11% 186
2021
Q4
$4.73M Sell
21,523
-891
-4% -$196K 0.09% 218
2021
Q3
$4.07M Sell
22,414
-205
-0.9% -$37.2K 0.08% 224
2021
Q2
$4.56M Sell
22,619
-267
-1% -$53.8K 0.09% 212
2021
Q1
$4.92M Sell
22,886
-782
-3% -$168K 0.11% 196
2020
Q4
$5.59M Sell
23,668
-414
-2% -$97.9K 0.13% 179
2020
Q3
$6.55M Sell
24,082
-412
-2% -$112K 0.16% 139
2020
Q2
$7.11M Sell
24,494
-1,167
-5% -$339K 0.18% 128
2020
Q1
$6.11M Sell
25,661
-409
-2% -$97.3K 0.17% 136
2019
Q4
$5.71M Sell
26,070
-812
-3% -$178K 0.13% 178
2019
Q3
$4.55M Sell
26,882
-140
-0.5% -$23.7K 0.1% 208
2019
Q2
$4.96M Buy
27,022
+336
+1% +$61.6K 0.11% 182
2019
Q1
$4.91M Buy
26,686
+164
+0.6% +$30.2K 0.12% 179
2018
Q4
$4.4M Buy
26,522
+173
+0.7% +$28.7K 0.12% 176
2018
Q3
$5.08M Buy
26,349
+65
+0.2% +$12.5K 0.12% 176
2018
Q2
$4.47M Buy
26,284
+164
+0.6% +$27.9K 0.11% 196
2018
Q1
$4.26M Buy
26,120
+200
+0.8% +$32.6K 0.11% 195
2017
Q4
$3.88M Buy
25,920
+365
+1% +$54.7K 0.1% 214
2017
Q3
$3.89M Buy
25,555
+369
+1% +$56.1K 0.1% 208
2017
Q2
$3.25M Buy
25,186
+257
+1% +$33.1K 0.09% 236
2017
Q1
$2.73M Buy
24,929
+44
+0.2% +$4.81K 0.07% 261
2016
Q4
$1.83M Buy
24,885
+352
+1% +$25.9K 0.05% 342
2016
Q3
$2.14M Buy
24,533
+357
+1% +$31.1K 0.06% 304
2016
Q2
$2.08M Buy
24,176
+214
+0.9% +$18.4K 0.06% 298
2016
Q1
$1.91M Buy
23,962
+291
+1% +$23.1K 0.05% 318
2015
Q4
$2.98M Buy
23,671
+627
+3% +$78.9K 0.09% 221
2015
Q3
$2.4M Sell
23,044
-92
-0.4% -$9.58K 0.08% 238
2015
Q2
$2.86M Buy
23,136
+480
+2% +$59.3K 0.09% 232
2015
Q1
$2.67M Buy
22,656
+819
+4% +$96.6K 0.08% 250
2014
Q4
$2.59M Buy
21,837
+855
+4% +$102K 0.08% 234
2014
Q3
$2.36M Buy
20,982
+9
+0% +$1.01K 0.08% 249
2014
Q2
$1.99M Buy
20,973
+58
+0.3% +$5.49K 0.07% 274
2014
Q1
$1.48M Buy
20,915
+174
+0.8% +$12.3K 0.05% 314
2013
Q4
$1.54M Buy
20,741
+131
+0.6% +$9.73K 0.06% 307
2013
Q3
$1.56M Sell
20,610
-12,565
-38% -$953K 0.06% 290
2013
Q2
$2.65M Buy
+33,175
New +$2.65M 0.11% 198